Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Nashville, Tennessee 37232


Purpose:

This pilot clinical trial studies a pain management smartphone application for monitoring pain in patients with locally advanced head and neck cancer who are undergoing radiation therapy. The study is also open to patients with esophageal or lung cancer. A smartphone application may allow patients to assess their symptoms in a manner that is closer to real-time than having to recall pain episodes during once weekly on-treatment visits with a health care provider. This real-time monitoring may improve the timing and efficacy of interventions leading to better pain-control and quality of life.


Study summary:

PRIMARY OBJECTIVES: I. Obtain consumer input to determine the optimal way to address and monitor the patient's symptoms. II. Train patients to use the pain management smartphone application (PMSA) and determine the compliance characteristics and the number of additional on-treatment visits (OTVs) prompted by usage of the application. OUTLINE: Selected patients are interviewed for input that will help guide the wording of questions of the PMSA. All patients/caregivers are then instructed to download the PMSA and are demonstrated how to properly use the application. Beginning on the first day of radiation therapy (day 1), patients are instructed to use the PMSA for the duration of their radiation therapy (up to day 50), although the timing may change based on the availability of the app.


Criteria:

Inclusion Criteria: - Radiation oncology patients undergoing 5-7 weeks of definitive radiation therapy for head and neck, esophageal or lung cancer. - Ability to understand and the willingness to use the PMSA on the patient's personal smartphone - Displays ability to use and understand the PMSA as evidenced by successful response to alarm and successful entries while monitored by the principal investigator (PI) - Willing and able to provide informed consent and fill out demographic, disease, and pain assessment questionnaires - English speaking Exclusion Criteria: - Radiation oncology patients undergoing palliative courses of radiation - Patients who do not own smartphones - Patients who are unable to successfully respond to the PMSA alarm and properly enter their data - Patients who are unable to eat and drink normally - Patients who are unable to validate their understanding of the pain scale


NCT ID:

NCT02324881


Primary Contact:

Principal Investigator
Jeffrey Friedman
Vanderbilt-Ingram Cancer Center


Backup Contact:

N/A


Location Contact:

Nashville, Tennessee 37232
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: November 22, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.